Gilead Sciences, Inc.GILDNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-24.8%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-24.8%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 2.40% |
| 2024 | 6.04% |
| 2023 | -0.60% |
| 2022 | -0.09% |
| 2021 | 10.60% |
| 2020 | 9.98% |
| 2019 | 1.46% |
| 2018 | -15.24% |
| 2017 | -14.09% |
| 2016 | -6.89% |